Vimarsana
Biggest News Aggregation in the World

Page 19 - Bio Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Developments Today - Breaking & Trending Today

Cell and gene therapy will be top industry trend for pharma in 2024 - Vimarsana News

Cell and gene therapy will be top industry trend for pharma in 2024

Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by data and analytics firm GlobalData.

Casgevy approval unlikely to be followed up by another CRISPR drug in near future - Vimarsana News

Casgevy approval unlikely to be followed up by another CRISPR drug in near future

Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, Casgevy.

FDA approves AstraZeneca and Ionis' treatment for ATTR polyneuropathy - Vimarsana News

FDA approves AstraZeneca and Ionis' treatment for ATTR polyneuropathy

AstraZeneca and Ionis have received FDA approval for Waiuna, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR).

Shorla Oncology and Eversana announce US launch of first oral methotrexate solution - Vimarsana News

Shorla Oncology and Eversana announce US launch of first oral methotrexate solution

Irish pharmaceutical company Shorla Oncology and consultancy firm Eversana have announced the U.S. launch of JYLAMVO, the first oral methotrexate solution.

AstraZeneca and Sanofi's RSV infant vaccine receives approval in China - Vimarsana News

AstraZeneca and Sanofi's RSV infant vaccine receives approval in China

AstraZeneca and Sanofi’s respiratory syncytial virus (RSV) vaccine for infants has received approval for use in China.